Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.74
(2.78%)
HKD 0.74
(2.78%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 557.32 Million CNY | -8.14% |
| 2022 | 606.7 Million CNY | -15.18% |
| 2021 | 715.29 Million CNY | 44.25% |
| 2020 | 495.88 Million CNY | 21.07% |
| 2019 | 409.59 Million CNY | 36.03% |
| 2018 | 301.11 Million CNY | 32.09% |
| 2017 | 227.97 Million CNY | 13.6% |
| 2016 | 200.68 Million CNY | -13.88% |
| 2015 | 233.02 Million CNY | 31.52% |
| 2014 | 177.18 Million CNY | 74.94% |
| 2013 | 101.28 Million CNY | 10.73% |
| 2012 | 91.47 Million CNY | 58.66% |
| 2011 | 57.65 Million CNY | 8.07% |
| 2010 | 53.34 Million CNY | 24.16% |
| 2009 | 42.96 Million CNY | 9.07% |
| 2008 | 39.39 Million CNY | 71.63% |
| 2007 | 22.95 Million CNY | 219.68% |
| 2006 | 7.18 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 475.4 Million CNY | 0.0% |
| 2023 FY | 557.32 Million CNY | -8.14% |
| 2023 Q4 | 557.32 Million CNY | 0.0% |
| 2023 Q2 | 615.29 Million CNY | 0.0% |
| 2022 FY | 606.7 Million CNY | -15.18% |
| 2022 Q2 | 700.68 Million CNY | 0.0% |
| 2022 Q4 | 606.7 Million CNY | 0.0% |
| 2021 FY | 715.29 Million CNY | 44.25% |
| 2021 Q2 | 565.71 Million CNY | 0.0% |
| 2021 Q4 | 715.29 Million CNY | 0.0% |
| 2020 Q4 | 495.88 Million CNY | 0.0% |
| 2020 Q2 | 439.71 Million CNY | 0.0% |
| 2020 FY | 495.88 Million CNY | 21.07% |
| 2019 FY | 409.59 Million CNY | 36.03% |
| 2019 Q2 | 365.1 Million CNY | 0.0% |
| 2019 Q4 | 409.59 Million CNY | 0.0% |
| 2018 Q4 | 301.11 Million CNY | 0.0% |
| 2018 Q2 | 282.01 Million CNY | 0.0% |
| 2018 FY | 301.11 Million CNY | 32.09% |
| 2017 Q4 | 227.97 Million CNY | 0.0% |
| 2017 FY | 227.97 Million CNY | 13.6% |
| 2017 Q2 | 228.5 Million CNY | 0.0% |
| 2016 Q2 | 265.89 Million CNY | 0.0% |
| 2016 Q4 | 200.68 Million CNY | 0.0% |
| 2016 FY | 200.68 Million CNY | -13.88% |
| 2015 Q4 | 233.02 Million CNY | 0.0% |
| 2015 Q2 | 222.52 Million CNY | 0.0% |
| 2015 FY | 233.02 Million CNY | 31.52% |
| 2014 Q2 | 129.31 Million CNY | 0.0% |
| 2014 Q4 | 177.18 Million CNY | 0.0% |
| 2014 FY | 177.18 Million CNY | 74.94% |
| 2013 Q2 | 129.75 Million CNY | 0.0% |
| 2013 Q4 | 101.28 Million CNY | 0.0% |
| 2013 FY | 101.28 Million CNY | 10.73% |
| 2012 FY | 91.47 Million CNY | 58.66% |
| 2012 Q4 | 91.47 Million CNY | 0.0% |
| 2012 Q2 | 69.28 Million CNY | 0.0% |
| 2011 Q4 | 57.65 Million CNY | 0.0% |
| 2011 FY | 57.65 Million CNY | 8.07% |
| 2011 Q2 | 77.73 Million CNY | 0.0% |
| 2010 FY | 53.34 Million CNY | 24.16% |
| 2010 Q4 | 53.34 Million CNY | 0.0% |
| 2009 FY | 42.96 Million CNY | 9.07% |
| 2008 FY | 39.39 Million CNY | 71.63% |
| 2007 FY | 22.95 Million CNY | 219.68% |
| 2006 FY | 7.18 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -4469.345% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 59.866% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -7571.342% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -80.891% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -29.074% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -86.955% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -787.147% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -467.158% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -217.388% |
| SSY Group Limited | 1.08 Billion HKD | 48.694% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -508.531% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -75.338% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 98.412% |